Spironolactone (oral)
An anti-androgen oral medication used off-label for adult hormonal acne and female pattern hair loss.
Blocks androgen receptors and reduces testosterone synthesis, lowering DHT effects on sebum and follicles.
- Effective for hormonal acne
- Helps female pattern hair loss
What the evidence supports.
- All skin types
- Pregnant
- Hyperkalemia
- Renal impairment
Apply early in routine, toner/essence step.
Concentration range in well-formulated products: Oral 25–200mg
Year-round.
Monitor potassium, limit high-K foods if doctor advises.
No specific deficiency signals tracked for this ingredient.
First-line for adult female hormonal acne; effects build over 8–12 weeks.
Spironolactone (oral) is a regulated medication. Use only under the guidance of a licensed physician or dermatologist. The information here is educational, Skinlumis does not dispense prescriptions or provide medical advice.
The research behind Spironolactone (oral).
Every claim on this page traces to published research. Findings below are drawn from randomized trials and systematic reviews, each links to the study on PubMed.
American Journal of Clinical Dermatology, 2020
Journal of Cutaneous Medicine and Surgery, 2020
Journal of Advanced Research, 2015
Dermato-Endocrinology, 2011
No flagged conflicts. Still, patch-test new actives.
Sign up to see how Spironolactone (oral) fits your skin archetype and personalised protocol.